​

Merck (MRK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MRK Stock Forecast

Merck (MRK) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $112.33, with a high of $122.00 and a low of $90.00. This represents a 13.44% increase from the last price of $99.02.

$90 $99 $108 $117 $126 $135 High: $122 Avg: $112.33 Low: $90 Last Closed Price: $99.02

MRK Stock Rating

Merck stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 25 Buy (69.44%), 10 Hold (27.78%), 1 Sell (2.78%), and 0 Strong Sell (0.00%).

Buy
Total 36 1 10 25 Strong Sell Sell Hold Buy Strong Buy

MRK Price Target Upside V Benchmarks

TypeNameUpside
StockMerck13.44%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks7.11%

Price Target Trends

1M3M12M
# Anlaysts5710
Avg Price Target$116.80$110.57$106.00
Last Closing Price$99.02$99.02$99.02
Upside/Downside17.96%11.66%7.05%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 2521413--29
Nov, 2521313--28
Oct, 2521313--28
Sep, 2521213--27
Aug, 2521213--27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 12, 2025Morgan Stanley$102.00$100.061.94%3.01%
Dec 10, 2025Rajesh KumarHSBC$120.00$96.8923.85%21.19%
Dec 05, 2025Guggenheim$122.00$100.8920.92%23.21%
Dec 04, 2025Louise ChenScotiabank$120.00$101.8817.79%21.19%
Dec 02, 2025Asad HaiderGoldman Sachs$120.00$101.8317.84%21.19%
Nov 03, 2025Terence FlynnMorgan Stanley$100.00$84.6518.13%0.99%
Sep 17, 2025Luisa HectorBerenberg Bank$90.00$81.1410.92%-9.11%
Jul 10, 2025Terence FlynnMorgan Stanley$98.00$84.3916.13%-1.03%
Apr 25, 2025Evan SeigermanBMO Capital$82.00$82.74-0.89%-17.19%
Feb 05, 2025Terence FlynnMorgan Stanley$106.00$90.7416.82%7.05%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 10, 2025HSBCBuyBuyhold
Dec 05, 2025GuggenheimBuyBuyhold
Dec 04, 2025ScotiabankOutperformOutperformhold
Dec 02, 2025Goldman SachsBuyBuyhold
Nov 24, 2025Wells FargoBuyOverweightupgrade
Jul 10, 2025Morgan StanleyUnderperformUnderperformhold
May 20, 2025Cantor FitzgeraldOverweightCautiousdowngrade
May 14, 2025CitigroupBuyNeutraldowngrade
Apr 25, 2025BMO CapitalMarket PerformMarket Performhold
Feb 05, 2025Goldman SachsBuyBuyhold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.79$5.16$5.73$0.14$6.74----
Avg Forecast$5.72$5.79$7.39$1.38$7.76$9.23$10.03$10.74$10.74
High Forecast$5.88$5.96$7.71$1.46$7.87$10.03$11.36$12.56$11.28
Low Forecast$5.56$5.63$7.17$1.33$7.64$7.89$8.36$8.52$10.51
Surprise %-51.22%-10.88%-22.46%-89.86%-13.14%----

Revenue Forecast

$40B $48B $56B $64B $72B $80B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$41.52B$48.70B$59.28B$60.12B$64.17B----
Avg Forecast$48.19B$48.52B$59.12B$59.97B$63.99B$67.11B$70.95B$74.43B$75.50B
High Forecast$49.25B$49.59B$61.06B$60.30B$64.28B$68.80B$71.14B$74.90B$78.42B
Low Forecast$47.14B$47.46B$57.78B$59.81B$63.75B$66.44B$70.77B$73.97B$74.24B
Surprise %-13.84%0.38%0.27%0.24%0.28%----

Net Income Forecast

$0 $7B $14B $21B $28B $35B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.07B$13.05B$14.52B$365.00M$17.12B----
Avg Forecast$5.03B$12.27B$14.91B$365.00M$19.76B$21.95B$24.45B$26.84B$27.37B
High Forecast$6.91B$14.72B$17.89B$438.00M$20.06B$25.55B$28.92B$32.00B$28.74B
Low Forecast$3.15B$9.81B$11.93B$292.00M$19.46B$20.09B$21.30B$21.71B$26.77B
Surprise %40.57%6.36%-2.62%--13.37%----

MRK Forecast FAQ

Is Merck stock a buy?

Merck stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 25 Buy, 10 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Merck is a favorable investment for most analysts.

What is Merck's price target?

Merck's price target, set by 36 Wall Street analysts, averages $112.33 over the next 12 months. The price target range spans from $90 at the low end to $122 at the high end, suggesting a potential 13.44% change from the previous closing price of $99.02.

How does Merck stock forecast compare to its benchmarks?

Merck's stock forecast shows a 13.44% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the drug manufacturers - general stocks industry (7.11%).

What is the breakdown of analyst ratings for Merck over the past three months?

  • December 2025: 6.90% Strong Buy, 48.28% Buy, 44.83% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 7.14% Strong Buy, 46.43% Buy, 46.43% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 7.14% Strong Buy, 46.43% Buy, 46.43% Hold, 0% Sell, 0% Strong Sell.

What is Merck’s EPS forecast?

Merck's average annual EPS forecast for its fiscal year ending in December 2025 is $9.23, marking a 36.94% increase from the reported $6.74 in 2024. Estimates for the following years are $10.03 in 2026, $10.74 in 2027, and $10.74 in 2028.

What is Merck’s revenue forecast?

Merck's average annual revenue forecast for its fiscal year ending in December 2025 is $67.11B, reflecting a 4.58% increase from the reported $64.17B in 2024. The forecast for 2026 is $70.95B, followed by $74.43B for 2027, and $75.5B for 2028.

What is Merck’s net income forecast?

Merck's net income forecast for the fiscal year ending in December 2025 stands at $21.95B, representing an 28.26% increase from the reported $17.12B in 2024. Projections indicate $24.45B in 2026, $26.84B in 2027, and $27.37B in 2028.